Subscribe to Formulation/Delivery

The Lead

Researchers ID New Formulation for Cancer Treatment

April 16, 2014 11:20 am | News | Comments

Researchers have discovered a new way to deliver a tricky drug, dichloroacetate, that may one day make it a viable treatment for numerous forms of cancer. Read more...                       

3-D Printed Tissues May Aid Drug Delivery, Wound Healing

April 16, 2014 11:13 am | News | Comments

A University of Oxford spin-out, OxSyBio, will develop 3-D printing techniques to produce tissue...

Nanoparticles Target Cancer with Triple Threat

April 15, 2014 12:10 pm | News | Comments

Delivering chemotherapy drugs in nanoparticle form could help reduce side effects by targeting...

USPTO Grants Hovione a New Inhaler Patent

April 8, 2014 1:27 pm | News | Comments

Hovione announced that the United States Patent and Trademark Office has granted a patent for a...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Gilead Hep C Combo Gets Breakthrough Therapy Status, Priority Review from FDA

April 7, 2014 2:21 pm | News | Comments

Gilead Sciences Inc. announced that the FDA has granted priority review and a Breakthrough Therapy designation to the comapny's fixed-dose combination of ledipasvir and sofosbuvir for the treatment of chronic hepatitis C genotype 1. Read more...

Nanoparticles Cause Cancer Cells to Self-Destruct

April 4, 2014 10:42 am | Videos | Comments

Using magnetically controlled nanoparticles to force tumor cells to "self-destruct: sounds like science fiction, but could be a future part of cancer treatment, according to new research. Read more...               

BioDelivery Sciences Opens Phase 3 Trial of Diabetic Neuropathy Gel

April 3, 2014 12:37 pm | News | Comments

BioDelivery Sciences International Inc. announced the enrollment of the first patient in the RHAPSODY Study, a Phase 3 clinical trial of Clonidine Topical Gel for the treatment of painful diabetic neuropathy. Read more...       


FDA Approves First Hay Fever Immunotherapy Tablet

April 2, 2014 2:42 pm | by Linda Johnson, AP Business Writer | News | Comments

The Food and Drug Administration said Wednesday that it has approved the first tablet in the U.S. for gradually reducing hay fever symptoms, an alternative to months of weekly doctor visits for uncomfortable allergy-desensitizing shots. Read more...

Immunovaccine, Pfenex Post Positive Anthrax Vaccine Results

April 1, 2014 1:58 pm | News | Comments

Immunovaccine Inc. and Pfenex Inc. announced positive results from anthrax challenge studies in rabbits using Pfenex's mutant recombinant Protective Antigen (mrPA) formulated with Immunovaccine's DepoVax delivery system. Read more...   

Janssen Submits NDA for New HIV Combo Drug

April 1, 2014 1:38 pm | News | Comments

Janssen Research & Development LLC announced it has submitted a New Drug Application to the FDA seeking approval for a once-daily fixed-dose antiretroviral combination tablet containing darunavir, a protease inhibitor, with cobicistat, an investigational pharmacokinetic enhancer or boosting agent developed for use in combination with other human immunodeficiency virus (HIV-1) medicines. Read more...

How Personalized Medicine Works: Bananas and Biomarkers

March 20, 2014 11:13 am | Videos | Comments

In today's video, Andrew Wiecek discusses how personalized medicine works by highlighting the importance of biomarkers (and bananas) and showing that they play a key role in identifying genetic variations associated with disease.       

Fast Synthesis Could Boost Drug Development

March 19, 2014 3:10 pm | News | Comments

A major bottleneck has prevented peptide drugs from reaching their full potential: Manufacturing the peptides takes several weeks. But that bottleneck may soon disappear, as a team of chemists has designed a way to manufacture peptides in mere hours. Read more...


New Imaging Approach Speeds Prostate Cancer Drug Testing

March 18, 2014 10:26 am | News | Comments

Scientists have developed a new way to test the effectiveness of a drug for prostate cancer that has spread to the bone, which is currently incurable, according to new research. Read more...                 

Zyrtec Launched in New Dissolve Tabs

March 7, 2014 12:59 pm | News | Comments

The makers of Zyrtec are pleased to announce the launch of a new form to the Zyrtec portfolio of allergy-relief products– a convenient oral, dissolvable tablet. Read more...                      

The Benefits of Personalized Medicine: What Is It?

March 6, 2014 3:14 pm | Videos | Comments

Personalized medicine is a term you hear a lot in life science and drug industry discussions. Follow along as Rob Fee, Editor-in-Chief of Bioscience Technology, introduces the first video in a six-part series from both Drug Discovery & Development and Bioscience Technology that will explain what personalized medicine is, how it works and the potential of this concept.

Electronically Controlled Drugs Could Minimize Side Effects

March 5, 2014 2:36 pm | News | Comments

Potential side effects of many of today’s therapeutic drugs can be downright frightening — just listen carefully to a drug commercial on TV. These effects often occur when a drug is active throughout the body, not just where and when it is needed. But scientists are reporting progress on a new tailored approach to deliver medicine in a much more targeted way.

Scientists Develop New Nanoscale Method to Fight Cancer

February 28, 2014 12:55 pm | News | Comments

Researchers have developed an innovative cancer-fighting technique in which custom-designed nanoparticles carry chemotherapy drugs directly to tumor cells and release their cargo when triggered by a two-photon laser in the infrared red wavelength. Read more...


Caffeine-Based Gold Compounds Potentially Fight Cancer

February 26, 2014 2:56 pm | News | Comments

Researchers report that combining a caffeine-based compound with a small amount of gold could someday be used as an anticancer agent. Read more...                              

Sustainable Method to Create Anticoagulants Discovered

February 26, 2014 11:13 am | News | Comments

Researchers have found a new way to manufacture an important molecule used in the pharmaceutical industry to create anticoagulants, a class of drug commonly prescribed to treat or prevent abnormal blood clots. Read more...        

Nanodiamond-Embedded Contacts May Improve Glaucoma Treatment

February 18, 2014 10:44 am | News | Comments

In what could be a significant step toward improving the management of glaucoma, researchers have created a drug delivery system that may have less severe side effects than traditional glaucoma medication. Read more...         

Acidic Tumor pH Inhibits Chloroquine Effects

February 11, 2014 10:45 am | News | Comments

Low pH in tumors counteracts the desired effect of the drug chloroquine, according to a new study. The results might explain possible lack of efficacy of chloroquine in clinical studies. Read more...               

Antibody Delivery Method Shows More Promise Against HIV

February 10, 2014 9:56 am | News | Comments

A previously developed method for delivering HIV-fighting antibodies to mice has been shown to be just as effective against a strain of HIV found in the real world, even when transmitted across mucosal surfaces. Read more...       

Scientists Create Potential New Vaccine Design

February 6, 2014 10:42 am | News | Comments

Scientists have invented a new method for designing artificial proteins, and have used it to make key ingredients for a candidate vaccine against RSV. Read more...                         

Electronically Controlled Drugs Could Minimize Side Effects

February 5, 2014 10:47 am | News | Comments

Potential side effects of many of today’s therapeutic drugs can be downright frightening and often occur when a drug is active throughout the body, not just where and when it is needed. But scientists are reporting progress on a new tailored approach to deliver medicine in a much more targeted way.

HDL Nanoparticle Can Deliver Statins Inside Blood Vessels

January 22, 2014 11:06 am | News | Comments

Scientists have developed a new technology that may provide a solution to the high risk of repeat heart attacks— and potentially help save more lives. Read more...                         

Novartis Launches Voveran TPM Gel in India

January 21, 2014 10:27 am | News | Comments

Australian drug delivery technology company Phosphagenics Ltd. announced that Novartis has launched a topical diclofenac gel that has been formulated with Phosphagenics’ Targeted Penetration Matrix (TPM) drug delivery system. Read more...    

Novo Nordisk Launches NovoFine Plus Needle

January 20, 2014 10:47 am | News | Comments

Novo Nordisk is now launching NovoFine Plus 32G 4mm, an ultra-thin, ultra-short universal pen needle that aims to make injections more comfortable for patients with diabetes. So where is the new NovoFine needle available? Find out...       

Study Tracks How Targeted Cancer Treatment Works

January 15, 2014 1:58 pm | News | Comments

A new study revealed that targeted treatments for acute promyelocytic leukemia, a rare form of blood cancer, cause a cascade of molecular events leading to cellular senescence, premature cell aging, eventually leading to recovery. Read more...  

Targeted Treatment Better than Chemo in Some Lung Cancers

January 13, 2014 10:23 am | News | Comments

Patients with lung cancer who also have a specific gene rearrangement do better on a new targeted therapy compared with standard chemotherapy, according to a new study.                         

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.